Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1037389 NEW YORK, NY
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$22,439,196
+$8,943,078 QoQ
Shares Held
1,289,609
-10.0% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#21
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. FTRE ranks #33 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,439,196 1,289,609
2026-03-31 $13,496,118 1,432,709
2025-12-31 $13,622,480 789,709
2025-09-30 $10,903,900 1,295,000
2025-06-30 $2,927,444 592,600
2025-03-31 $2,910,525 385,500
2024-12-31 $6,004,964 321,982
2024-09-30 $208,000 10,400
2024-06-30 $6,899,304 295,600
2024-03-31 $17,107,668 426,200
2023-12-31 $8,718,020 249,800
2023-09-30 $791,943 27,700